Spotlight on Camrelizumab in Advanced Squamous Lung Cancer: Another Feather in the Cap of Chinese Checkpoint Inhibitors. Reguart N, Reyes R. J Thorac Oncol 2022;17:477-480.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Reguart N, Reyes R. Spotlight on Camrelizumab in Advanced Squamous Lung Cancer: Another Feather in the Cap of Chinese Checkpoint Inhibitors. J Thorac Oncol 2022;17:477-480.
PMID: 35307102